The Potential Application of Chinese Medicine in Liver Diseases: A New Opportunity

Overview

Journal Front Pharmacol

Date 2021 Nov 22

PMID 34803712

Citations 16

Authors

Ke Fu

Cheng Wang

Cheng Ma

Honglin Zhou

Yunxia Li

Affiliations

Soon will be listed here.

Abstract

Liver diseases have been a common challenge for people all over the world, which threatens the quality of life and safety of hundreds of millions of patients. China is a major country with liver diseases. Metabolic associated fatty liver disease, hepatitis B virus and alcoholic liver disease are the three most common liver diseases in our country, and the number of patients with liver cancer is increasing. Therefore, finding effective drugs to treat liver disease has become an urgent task. Chinese medicine (CM) has the advantages of low cost, high safety, and various biological activities, which is an important factor for the prevention and treatment of liver diseases. This review systematically summarizes the potential of CM in the treatment of liver diseases, showing that CM can alleviate liver diseases by regulating lipid metabolism, bile acid metabolism, immune function, and gut microbiota, as well as exerting anti-liver injury, anti-oxidation, and anti-hepatitis virus effects. Among them, Keap1/Nrf2, TGF-β/SMADS, p38 MAPK, NF-κB/IκBα, NF-κB-NLRP3, PI3K/Akt, TLR4-MyD88-NF-κB and IL-6/STAT3 signaling pathways are mainly involved. In conclusion, CM is very likely to be a potential candidate for liver disease treatment based on modern phytochemistry, pharmacology, and genomeproteomics, which needs more clinical trials to further clarify its importance in the treatment of liver diseases.

Citing Articles

Molecular Biological Mechanisms of Action of Chrysophanol in Hepatic Stellate Cells Activated by Hepatic B Virus X Based on Network Pharmacology.

Lin C, Cheng C, Chiou Y, Wang I, Kuo C Intervirology. 2024; 67(1):119-135.

PMID: 39647471 PMC: 11623962. DOI: 10.1159/000542355.

Traditional Chinese Medicine in post-resection liver cancer therapy: a meta-analysis of efficacy.

Wang J, Wang Y, Song C, Dong S, Yu Q Am J Transl Res. 2024; 16(10):5763-5775.

PMID: 39544735 PMC: 11558418. DOI: 10.62347/BWOA5995.

Banxia Xiexin Tang attenuates high glucose-induced hepatocyte injury by activating SOD2 to scavenge ROS via PGC-1α/IGFBP1.

Yang X, Yue R, Zhao L, Huang X, Wang Q 3 Biotech. 2024; 14(9):216.

PMID: 39220826 PMC: 11358567. DOI: 10.1007/s13205-024-04060-0.

New perspectives on chemokines in hepatocellular carcinoma therapy: a critical pathway for natural products regulation of the tumor microenvironment.

Ruishi X, Linyi X, Yunfan B, Wenbo Y, Xiaoying Z, Xiaoxue F Front Immunol. 2024; 15:1456405.

PMID: 39206194 PMC: 11349538. DOI: 10.3389/fimmu.2024.1456405.

Hovenia dulcis: a Chinese medicine that plays an essential role in alcohol-associated liver disease.

He Y, Liu M, Wang Y, Wu H, Wei M, Xue J Front Pharmacol. 2024; 15:1337633.

PMID: 38650630 PMC: 11033337. DOI: 10.3389/fphar.2024.1337633.

References

Gunduz E, Dursun R, Zengin Y, Icer M, Durgun H, Kanici A . Lycium barbarum extract provides effective protection against paracetamol-induced acute hepatotoxicity in rats. Int J Clin Exp Med. 2015; 8(5):7898-905. PMC: 4509291. View

Perez-Vargas J, Zarco N, Shibayama M, Segovia J, Tsutsumi V, Muriel P . Hesperidin prevents liver fibrosis in rats by decreasing the expression of nuclear factor-κB, transforming growth factor-β and connective tissue growth factor. Pharmacology. 2014; 94(1-2):80-9. DOI: 10.1159/000366206. View

Jang E, Kim S, Lee N, Yi C, Hong D, Lee W . Evaluation of antitumor activity of Artemisia capillaris extract against hepatocellular carcinoma through the inhibition of IL-6/STAT3 signaling axis. Oncol Rep. 2016; 37(1):526-532. DOI: 10.3892/or.2016.5283. View

Dewidar B, Meyer C, Dooley S, Meindl-Beinker A . TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019. Cells. 2019; 8(11). PMC: 6912224. DOI: 10.3390/cells8111419. View

Chuang H, Su H, Li C, Lin S, Yen S, Huang M . The Role of Butylidenephthalide in Targeting the Microenvironment Which Contributes to Liver Fibrosis Amelioration. Front Pharmacol. 2016; 7:112. PMC: 4847481. DOI: 10.3389/fphar.2016.00112. View

Zhou W, Zhang Q, Qiao L . Pathogenesis of liver cirrhosis. World J Gastroenterol. 2014; 20(23):7312-24. PMC: 4064077. DOI: 10.3748/wjg.v20.i23.7312. View

Wang Y, Wang R, Wang Y, Peng R, Wu Y, Yuan Y . Ginkgo biloba extract mitigates liver fibrosis and apoptosis by regulating p38 MAPK, NF-κB/IκBα, and Bcl-2/Bax signaling. Drug Des Devel Ther. 2015; 9:6303-17. PMC: 4671772. DOI: 10.2147/DDDT.S93732. View

Yokomori H, Oda M, Yoshimura K, Hibi T . Recent advances in liver sinusoidal endothelial ultrastructure and fine structure immunocytochemistry. Micron. 2011; 43(2-3):129-34. DOI: 10.1016/j.micron.2011.08.002. View

Mahmoud A, Hussein O, Hozayen W, Bin-Jumah M, Abd El-Twab S . Ferulic acid prevents oxidative stress, inflammation, and liver injury via upregulation of Nrf2/HO-1 signaling in methotrexate-induced rats. Environ Sci Pollut Res Int. 2020; 27(8):7910-7921. DOI: 10.1007/s11356-019-07532-6. View

10.

Kalyanaraman B . Teaching the basics of redox biology to medical and graduate students: Oxidants, antioxidants and disease mechanisms. Redox Biol. 2013; 1:244-57. PMC: 3757692. DOI: 10.1016/j.redox.2013.01.014. View

11.

Wang R, Zhang D, Tang D, Sun K, Peng J, Zhu W . Amygdalin inhibits TGFβ1-induced activation of hepatic stellate cells (HSCs) in vitro and CCl-induced hepatic fibrosis in rats in vivo. Int Immunopharmacol. 2020; 90:107151. DOI: 10.1016/j.intimp.2020.107151. View

12.

Crocenzi F, Zucchetti A, Boaglio A, Barosso I, Sanchez Pozzi E, Mottino A . Localization status of hepatocellular transporters in cholestasis. Front Biosci (Landmark Ed). 2011; 17(4):1201-18. DOI: 10.2741/3981. View

13.

Ceccarini M, Vannini S, Cataldi S, Moretti M, Villarini M, Fioretti B . Protective Effects of Berries Cultivated in Umbria (Italy) on Human Hepatocellular Carcinoma Cells. Biomed Res Int. 2016; 2016:7529521. PMC: 5124644. DOI: 10.1155/2016/7529521. View

14.

Wang J, Liao A, Thakur K, Zhang J, Huang J, Wei Z . Licochalcone B Extracted from Glycyrrhiza uralensis Fisch Induces Apoptotic Effects in Human Hepatoma Cell HepG2. J Agric Food Chem. 2019; 67(12):3341-3353. DOI: 10.1021/acs.jafc.9b00324. View

15.

Wei L, Dai Y, Zhou Y, He Z, Yao J, Zhao L . Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression. Cell Death Dis. 2017; 8(7):e2944. PMC: 5550876. DOI: 10.1038/cddis.2017.335. View

16.

Rakshit S, Shukla P, Verma A, Nirala S, Bhadauria M . Protective role of rutin against combined exposure to lipopolysaccharide and D-galactosamine-induced dysfunctions in liver, kidney, and brain: Hematological, biochemical, and histological evidences. J Food Biochem. 2021; 45(2):e13605. DOI: 10.1111/jfbc.13605. View

17.

Uchio R, Higashi Y, Kohama Y, Kawasaki K, Hirao T, Muroyama K . A hot water extract of turmeric () suppresses acute ethanol-induced liver injury in mice by inhibiting hepatic oxidative stress and inflammatory cytokine production. J Nutr Sci. 2017; 6:e3. PMC: 5465857. DOI: 10.1017/jns.2016.43. View

18.

Gan D, Zhang W, Huang C, Chen J, He W, Wang A . Ursolic acid ameliorates CCl4-induced liver fibrosis through the NOXs/ROS pathway. J Cell Physiol. 2018; 233(10):6799-6813. PMC: 6055678. DOI: 10.1002/jcp.26541. View

19.

Zou C, Su N, Wu J, Xu M, Sun Z, Liu Q . Dietary Radix Bupleuri extracts improves hepatic lipid accumulation and immune response of hybrid grouper (Epinephelus lanceolatus♂ × Epinephelus fuscoguttatus♀). Fish Shellfish Immunol. 2019; 88:496-507. DOI: 10.1016/j.fsi.2019.02.052. View

20.

Han B, Kim S, Nam G, Kim S, Park S, Park Y . A Randomized, Double-Blind, Placebo-Controlled, Multi-Centered Clinical Study to Evaluate the Efficacy and Safety of L. Extract for Improvement of Liver Function. Clin Nutr Res. 2020; 9(4):258-270. PMC: 7644367. DOI: 10.7762/cnr.2020.9.4.258. View